The utility of [11C]PBB3‐PET for detection of tau aggregates characteristic of PSP has been supported by the present data, implying clinicopathological correlations in specific brain areas including frontoparietal WM. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.